- Home
- TPIC vs NVNO Comparison
TPIC vs NVNO Comparison
Compare TPIC & NVNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TPIC
- NVNO
- Stock Information
- Founded
- TPIC 1968
- NVNO 1987
- Country
- TPIC United States
- NVNO United States
- Employees
- TPIC N/A
- NVNO N/A
- Industry
- TPIC Industrial Machinery/Components
- NVNO Medical/Dental Instruments
- Sector
- TPIC Industrials
- NVNO Health Care
- Exchange
- TPIC Nasdaq
- NVNO Nasdaq
- Market Cap
- TPIC 57.1M
- NVNO 55.2M
- IPO Year
- TPIC 2016
- NVNO N/A
- Fundamental
- Price
- TPIC $1.56
- NVNO $3.29
- Analyst Decision
- TPIC Hold
- NVNO
- Analyst Count
- TPIC 5
- NVNO 0
- Target Price
- TPIC $3.36
- NVNO N/A
- AVG Volume (30 Days)
- TPIC 3.4M
- NVNO 202.2K
- Earning Date
- TPIC 02-20-2025
- NVNO 02-27-2025
- Dividend Yield
- TPIC N/A
- NVNO N/A
- EPS Growth
- TPIC N/A
- NVNO N/A
- EPS
- TPIC N/A
- NVNO N/A
- Revenue
- TPIC $1,301,740,000.00
- NVNO N/A
- Revenue This Year
- TPIC N/A
- NVNO N/A
- Revenue Next Year
- TPIC $16.85
- NVNO N/A
- P/E Ratio
- TPIC N/A
- NVNO N/A
- Revenue Growth
- TPIC N/A
- NVNO N/A
- 52 Week Low
- TPIC $1.10
- NVNO $2.45
- 52 Week High
- TPIC $5.75
- NVNO $6.97
- Technical
- Relative Strength Index (RSI)
- TPIC 44.47
- NVNO 56.55
- Support Level
- TPIC $1.40
- NVNO $3.13
- Resistance Level
- TPIC $1.56
- NVNO $3.26
- Average True Range (ATR)
- TPIC 0.20
- NVNO 0.22
- MACD
- TPIC -0.00
- NVNO 0.02
- Stochastic Oscillator
- TPIC 22.40
- NVNO 47.33
About TPIC TPI Composites Inc.
TPI Composites Inc is engaged in manufacturing composite wind blades. The company operates in wind energy and transportation industries where it manufactures structures for a bus, rail, theme parks, and trucks. Geographically the segments are divided into the U.S, Asia, Mexico, EMEA and India where the Mexico segment derives a majority of revenue.
About NVNO enVVeno Medical Corporation
enVVeno Medical Corp is a medical device company focused on the development of bioprosthetic (tissue-based) devices to improve the standard of care in the treatment of venous disease. Its product, the VenoValve, is a first-in-class, surgical implant being developed for the treatment of severe deep venous Chronic Venous Insufficiency (CVI).